Sompo Asset Management Co., Ltd. Amgen Inc Transaction History

Sompo Asset Management Co., Ltd.

$536 Million
Q1 2025

A detailed history of Sompo Asset Management Co., Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Sompo Asset Management Co., Ltd. holds 4,046 shares of AMGN stock, worth $1.19 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

4,046

Previous 3,986 1.51%

Holding current value

$1.19 Million

Previous $1.04 Million 21.39%

% of portfolio

0.23%

Previous 0.18%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$258.59 - $327.36 $15,515 - $19,641	60 Added 1.51%	4,046 $1.26 Million
Q4 2024 Feb 14, 2025	SELL	$258.78 - $328.31 $208,576 - $264,617	-806 Reduced 16.82%	3,986 $1.04 Million
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $24,131 - $26,315	-78 Reduced 1.6%	4,792 $1.54 Million
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $68,315 - $83,020	-260 Reduced 5.07%	4,870 $1.52 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $99,481 - $120,087	370 Added 7.77%	5,130 $1.46 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $163,648 - $184,614	640 Added 15.53%	4,760 $1.37 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $247,074 - $306,749	-1,130 Reduced 21.52%	4,120 $1.11 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $13,547 - $16,512	60 Added 1.16%	5,250 $1.27 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $25,193 - $32,011	-110 Reduced 2.08%	5,190 $1.36 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $98,762 - $111,386	440 Added 9.05%	5,300 $1.19 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $1.12 Million - $1.25 Million	4,860 New	4,860 $1.18 Million

Others Institutions Holding AMGN

# of Institutions

3,310

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sompo Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sompo Asset Management Co., Ltd. with notifications on news.

Account

Sompo Asset Management Co., Ltd. Amgen Inc Transaction History